Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Shares Issued: 2023-2025

  • Inhibrx Biosciences' Shares Issued was N/A to $352,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $270.8 million, marking a year-over-year change of. This contributed to the annual value of $71.7 million for FY2024, which is 64.16% down from last year.
  • Inhibrx Biosciences' Shares Issued amounted to $352,000 in Q3 2025, which was down 98.93% from $33.0 million recorded in Q2 2024.
  • In the past 5 years, Inhibrx Biosciences' Shares Issued registered a high of $198.8 million during Q3 2023, and its lowest value of $352,000 during Q3 2025.
  • For the 3-year period, Inhibrx Biosciences' Shares Issued averaged around $67.7 million, with its median value being $35.8 million (2024).